The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Clinical

The Cancer Letter wins investigative, design awards

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS

The Cancer Letter won four 2019 Dateline Awards from the Washington, D.C. Chapter of the Society of Professional Journalists:

  • Investigative Journalism, Newsletter/Trade Publications, first place, for “When Surgical Innovation Kills,” by Matthew Ong
  • Front Page Design, Newsletter/Trade Publications, first place, by Jacqueline Ong and Katherine Goldberg
  • Photo Illustration, Newsletter/Trade Publications, first place, by Katherine Goldberg
  • Series, Newsletter/Trade Publications, finalist, for “From Rhetoric to Harm,” by Paul Goldberg and Matthew Ong

Ong has won six Dateline Awards over the past five years. This is the third time Ong has won a first-place Dateline Award for his investigative work on minimally invasive surgery and cancer-related outcomes.

Ong’s series has also received awards from six organizations, including the National Press Club, the national Society of Professional Journalists, and the National Institute for Health Care Management (The Cancer Letter, How Medical Devices do Harm, 2014-2017; When Surgical Innovation Kills, 2018-2019).

This is the second consecutive year The Cancer Letter has won first-place design awards.

Here are a few of The Cancer Letter’s award-winning covers published in 2018:

TCL44-43 copy
TCL44-30 copy
TCL44-06 copy
TCL44-16 copy
TCL44-28 copy
Table of Contents

YOU MAY BE INTERESTED IN

Clinical

Oncofertility coverage mandates expand to 21 states and DC as political momentum builds
Gaps persist as patients face harrowing decisions and huge copays

The nagging pain in Mia Sandino’s right knee set in in September 2018, and throughout her freshman year at the University of Washington, she tried to ignore it. “I was being a very naive and invincible-feeling 19-year-old,” Sandino told The Cancer Letter. “I didn’t put two and two together that this area of the knee that...

By Claire Marie Porter and Sara Willa Ernst
Guest Editorial

My introduction to, and lessons learned from, Rick Pazdur

Rick Pazdur, MD, the newly appointed director for the Center for Drug Evaluation and Research at the FDA, has been described as “greyhound thin” as a result of his dedication to cycling and lifting weights in the gym each day and, for a long time, a vegetarian diet. I first met him when he was the director of the Office of Oncology Drug Products (ODP) within CDER, in 2009.
By Mikkael A. Sekeres
Sponsored

Meeting the moment: ASCO GI Cancers Symposium delivers insights and collaboration

When it comes to fighting cancer today, collaboration is key. At a time when funding is uncertain, yet innovative breakthroughs are accelerating every day, it’s more important than ever for oncologists, scientists, academic researchers, and community physicians, to come together to share knowledge and gain insights about the forefront of cancer research.
By The American Society of Clinical Oncology
Table of Contents

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account